List of Figures
List of Figures
Regulatory Intelligence on Biologics Recalls, Total Number of Biologics Recalls, 2004–2010
Figure 1: Regulatory Intelligence on Biologics Recalls, Total Number of Recalls by All Agencies, 2007–2010
Figure 2: Regulatory Intelligence on Biologics Recalls, Drug Recalls by CDER, 2007, 2008 and 2010
Figure 3: Regulatory Intelligence on Biologics Recalls, Number of Drug Product Recalls by CDER by Class, 2007, 2008 and 2010
Figure 4: Regulatory Intelligence on Biologics Recalls, Drug Recalls by CBER, 2007, 2008 and 2010
Figure 5: Regulatory Intelligence on Biologics Recalls, Number of Biological Product Recalls by CBER by Class, 2007, 2008 and 2010
Figure 6: Regulatory Intelligence on Biologics Recalls, Product Recalls by CDER, CBER and Other Agencies, 2007, 2008 and 2010
Figure 7: Regulatory Intelligence on Biologics Recalls, Biologics Manufacturing, Biologics Classification, 2009
Figure 8: Regulatory Intelligence on Biologics Recalls, Biologics Manufacturing, Biologics Manufacturing Steps, 2009
Figure 9: Regulatory Intelligence on Biologics Recalls, Reasons for Manufacturing Initiating Recalls
Figure 10: Regulatory Intelligence on Biologics Recalls, FDA Responsibilities
Figure 11: Regulatory Intelligence on Biologics Recalls, Total Number of Biologics Recalls, 2004–2010
Figure 12: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Reason for Recall, 2004–2010
Figure 13: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Therapy Area, 2004–2010
Figure 14: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Drug Class, 2004–2010
Figure 15: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Dosage Form, 2004–2010
Figure 16: Regulatory Intelligence on Biologics Recalls, Recalls by Companies, 2004–2010
Figure 17: Regulatory Intelligence on Biologics Recalls, Recalls by Companies, By Year, 2004–2010
Figure 18: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Reason for Recall, 2007–2010
Figure 19: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Therapy Area, 2007–2010
Figure 20: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Drug Class, 2007–2010
Figure 21: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Dosage Form, 2007–2010
Figure 22: Regulatory Intelligence on Biologics Recalls, Recalls by Companies, 2007–2010
Figure 23: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Reason for Recall (%), 2007
Figure 24: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Therapy Area (%), 2007
Figure 25: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Drug Class (%), 2007
Figure 26: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Dosage Form (%), 2007
Figure 27: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Companies (%), 2007
Figure 28: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Reason for Recall (%), 2008
Figure 29: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Therapy Area (%), 2008
Figure 30: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Drug Class (%), 2008
Figure 31: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Dosage Form (%), 2008
Figure 32: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Companies (%), 2008
Figure 33: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Reason for Recall (%), 2009
Figure 34: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Companies (%), 2009
Figure 35: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Reason for Recall (%), 2010
Figure 36: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Therapy Area (%), 2010
Figure 37: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Drug Class (%), 2010
Figure 38: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Dosage Form (%), 2010
Figure 39: Regulatory Intelligence on Biologics Recalls, Biologics Recalls by Companies (%), 2010